Formex LLC is a leading contract development and manufacturing organization focusing on oral and topical dosage forms.
Formex specializes in bioavailability enhancement and controlled release technologies, such as hot melt extrusion and spray drying.
Formex provides pre-formulation, formulation development, analytical method development, analytical testing, pre-clinical manufacturing, cGMP clinical trial manufacturing for Phase 0-IIb & small scale cytotoxic and high potent compound manufacturing.
Formex is a wholly-owned subsidiary of the Biotech Investment Group (BIG). BIG, founded in 2006, is a provider of growth equity capital to emerging healthcare services companies. BIG’s mission is to partner with outstanding entrepreneurs to build long-lasting companies and deliver services which address significant unmet healthcare needs.